Concepedia

Publication | Closed Access

Motor Progression and Nigrostriatal Neurodegeneration in Parkinson Disease

35

Citations

40

References

2022

Year

Abstract

We propose striatal dopaminergic terminal loss measured using <sup>123</sup> I-ioflupane SPECT and nigral dopamine neuron loss assessed with NM-MRI as early stage and advanced stage motor impairment biomarkers, respectively. ANN NEUROL 2022;92:110-121.

References

YearCitations

Page 1